Cortical and Corticomuscular Beta‐Gamma Phase‐Amplitude Coupling During Different Locomotion States and the Effects of Levodopa in Parkinson's Disease
Movement Disorders · 2025
DOI: 10.1002/mds.70031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, 2025. Verfasst von Haifeng Zhao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Neurosurgery, Affiliated Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Parkinson Disease, Levodopa, Antiparkinson Agents, Beta Rhythm. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, China Postdoctoral Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Phase‐amplitude coupling (PAC) in the beta‐gamma range has emerged as a promising electrophysiological biomarker of Parkinson's disease (PD).
Objective
This study aims to investigate how levodopa and locomotion modulate cortical (central electroencephalogram [cEEG]) and corticomuscular (cEEG‐gEMG [gastrocnemius electromyography]) beta‐gamma PAC in patients with PD.
Methods
Thirty patients with PD underwent simultaneous cEEG and gEMG recordings during sitting, standing, and free walking in both off and on dopaminergic states. Spectral features and PAC analyses were conducted to assess the effects of levodopa, locomotion, and their associations with motor symptoms.
Results
In the off levodopa state, patients showed prolonged gait cycle intervals and shorter step lengths, correlating with higher Movement Disorder Society–revised Unified Parkinson's Disease Rating Scale Part III (UPDRS‐III) scores. The cEEG beta‐gamma PAC during sitting and standing, and cEEG‐gEMG beta‐gamma PAC during walking, positively correlated with UPDRS‐III in the off levodopa state. The cEEG alpha/low beta‐gamma and cEEG‐gEMG low beta‐gamma PAC increased from on to off levodopa while walking, with the latter correlating with reduced step length. Step event–related PAC analysis unveiled a dynamic enhancement of alpha/beta cEEG‐gamma gEMG PAC around heel strikes in on levodopa compared with off .
Conclusions
Both cortical and corticomuscular beta‐gamma PACs are modulated by levodopa and locomotion, with low beta‐gamma corticomuscular PAC specifically linked to gait dysfunction. Moreover, the levodopa‐related enhancement of alpha/beta–gamma PAC during heel strikes highlights the functional relevance of dopaminergic modulation during gait. These findings highlight the potential of PAC as a biomarker for PD, particularly in the development of gait phase‐locked adaptive deep brain stimulation strategies for patients with PD guided by noninvasive PAC monitoring. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Functional Neurosurgery, Affiliated Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Radiology, Affiliated Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Clinical Neuroscience Center, Affiliated Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Clinical Neuroscience Center, Affiliated Ruijin Hospital Luwan Branch, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- MRC Brain Network Dynamics Unit, Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.
- Paris Brain Institute, CNRS UMR 7225, INSERM 1127, Sorbonne University, Paris, France.
ORCID-Profile: Haifeng Zhao, Shenghong He, Marie-Laure Welter, Huiling Tan, Chunyan Cao
Förderung
- Science and Technology Commission of Shanghai Municipality
- China Postdoctoral Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Zhao, H., Hao, S., Zhang, P., He, S., Wehmeyer, L., Feng, Z., Xu, L., Zhan, S., Liu, W., Zhang, X., Welter, M. L., Li, D., Sun, B., Lu, Y., Tan, H., & Cao, C. (2025). Cortical and Corticomuscular Beta‐Gamma Phase‐Amplitude Coupling During Different Locomotion States and the Effects of Levodopa in Parkinson's Disease. Movement Disorders. https://doi.org/10.1002/mds.70031
Vancouver
Zhao H, Hao S, Zhang P, He S, Wehmeyer L, Feng Z, et al. Cortical and Corticomuscular Beta‐Gamma Phase‐Amplitude Coupling During Different Locomotion States and the Effects of Levodopa in Parkinson's Disease. Movement Disorders. 2025. doi:10.1002/mds.70031
BibTeX
@article{Zhao2025,
author = {Zhao, Haifeng and Hao, Shenglin and Zhang, Peiran and He, Shenghong and Wehmeyer, Laura and Feng, Ziyi and Xu, Lu and Zhan, Shikun and Liu, Wei and Zhang, Xiaoxiao and Welter, Marie-Laure and Li, Dianyou and Sun, Bomin and Lu, Yong and Tan, Huiling and Cao, Chunyan},
title = {Cortical and Corticomuscular Beta‐Gamma Phase‐Amplitude Coupling During Different Locomotion States and the Effects of Levodopa in Parkinson's Disease},
journal = {Movement Disorders},
year = {2025},
doi = {10.1002/mds.70031}
}
EUVIMED